The Business of Biologics: Calling Attention to Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies for Maximizing Global Success
- Identifying approved and marketed biologics coming off patent while looking ahead and considering clinical insights, pricing and dosages
- Predicting what problems future competitors may run into with respect to their IP profiles
- Forecasting which segments or regions will drive market growth
- Reviewing key sustainability tactics adopted by leading market players
- Evaluating the impact of off-patent drugs on competition and growth strategies
- Developing techniques for an accurate assessment of the current value of your portfolio while